Optomax
Conference
Perth
Sunday 3 May 2015
McCusker Auditorium
Harry Perkins Institute
limited tickets
$349*
*earlybird pricing
there’s only
50
*earlybird tix
available
day
e
n
o
n
i
oints
p
D
P
ace C
f
o
t
& face
c
i
t
u
nce
e
ape
r
r
e
e
f
h
n
t
o
early
day C
y
e
r
n
u
o
o
All y
ndly
e
i
r
f
y
l
fami
ime
t
d
n
m
a
u
inim
Work
M
/
s
t
poin
m
u
m
i
m.au
Max
.co
x
a
m
pto
o
t
a
ow
n
r
e
t
Regis
31.5 Accredited CPD
Points applied for
Speakers
Th e Au st ralia n I nst it u t e of Opt omet r y
C o n f e r e n c e
2 0 1 1
Maximum CPD. Minimum Time.
A/Prof Angus Turner
Dr Angus Turner completed medical training at The University of Western Australia (UWA), before studying at Oxford University
and completing a Masters of Evidence Based Medicine. Ophthalmology training was undertaken in Melbourne, followed by
post-graduate training at University of Sydney in refractive surgical procedures. As Director of Outback Vision, Dr Turner is
actively involved in the delivery of specialist outreach services to remote and Indigenous communities in the Kimberley, Pilbara,
Goldfields, Great Southern, and South West regions. Dr Turner is an Associate Professor at UWA, where he is engaged in a
number of research projects at the Lions Eye Institute, focusing on service delivery for remote and Indigenous people. Dr Turner
is also a consultant at Fremantle Hospital and an ophthalmology teacher for the Rural Clinical School.
A/Prof Steven Wiffen
MB BS, FRACO, FRACS
Associate Professor Wiffen trained in ophthalmology in Western Australia before undertaking fellowships at the CorneoPlastic Unit, East Grinstead, UK, and at the Mayo Clinic, Rochester, Minnesota, USA Associate Professor Wiffen is a consultant
ophthalmologist at Fremantle Hospital and a Senior Lecturer at UWA He is Director of the Lions Eye Bank of Western Australia.
Dr Jean-Louis deSousa
Dr deSousa trained in ophthalmology in Perth before completing fellowships in ophthalmic plastic and reconstructive surgery in
Oxford and East Grinstead in the UK. He is a member of the Australian and New Zealand Society of Ophthalmic Plastic Surgeons. A
consultant ophthalmologist at Royal Perth Hospital he also provides ophthalmic services to the central wheatbelt from Merredin.
Dr deSousa is the WA representative for continuing professional development and a basic sciences examiner for RANZCO.
Prof Geoffrey Crawford
MBBS, FRANZCO, FRACS
Professor Crawford completed his ophthalmic training in Western Australia before undertaking further sub-speciality training
in cornea and refractive surgery at Moorfields Eye Hospital, London, and Emory University, Atlanta, USA He is a Professor of
Ophthalmology at the Centre for Ophthalmology and Visual Science, University of Western Australia He is Director of Surgical Services
and a Corneal and Refractive surgeon at the Lions Eye Institute, Perth and is also a consultant ophthalmic surgeon at Royal Perth
and Princess Margaret Hospitals. Professor Crawford has held many positions within RANZCO including Director of Continuing
Professional Development, inaugural Chairman of the Programme Committee and Chairman of Examiners. He is a co-inventor of the
AlphaCor artificial cornea and developed the techniques of its insertion. He also introduced LASIK surgery to Western Australia
Dr Andrea Ang
MBBS, MPH. Dr Ang completed her ophthalmic training in Western Australia before embarking on a Cornea, External Diseases, and
Anterior Segment Fellowship at the Cincinnati Eye Institute, Ohio, USA She is currently completing a second Cornea Fellowship at the
Singapore National Eye Centre, Singapore She was awarded a UWA Overseas Medical Fellowship and has written several publications
and book chapters on ocular surface disease during her Fellowship. Her interests include ocular surface reconstruction techniques
including limbal stem cell transplantation and keratoprostheses, and lamellar keratoplasty techniques, including anterior lamellar
keratoplasty and Descemet’s stripping endothelial keratoplasty.
Prof Ian McAllister
Professor McAllister undertook training in Western Australia with additional sub-specialty training in vitreoretinal disorders in the USA
He is Director of Clinical Services at Lions Eye Institute and a consultant ophthalmologist at King Edward Memorial Hospital for Women
and the Royal Perth, Sir Charles Gairdner and Princess Margaret Hospitals. Professor McAllister is actively involved in research for cures
for vitreoretinal disorders, especially retinal vascular disorders, and has held six NHMRC grants in this area He has been involved for
many years in state wide diabetic retinopathy screening and treatment services and coordinates and reviews photographs from diabetic
screening in remote parts of Western Australia Professor McAllister is currently vice chairman of the Ophthalmic Research Institute of
Australia and has been chairman of the Research Board for many years.
A/Prof Mei-Ling Tay-Kearney
Associate Professor Tay-Kearney completed her medical training in Perth, Western Australia before pursuing postgraduate study
at Johns Hopkins Hospital in Baltimore, USA In 2003 Associate Professor Tay-Kearney was appointed Head of Department of
Ophthalmology at Royal Perth Hospital. She is a Senior Lecturer at UWA and a member of the Australian Society for HIV Medicine and
the Australian Uveitis Study Group. She is the Chair of Qualifications and Education as well as an Examiner for the RANZCO Part 2
College examinations.
Dr Vignesh Raja
Dr. Vignesh Raja is a consultant ophthalmologist and vitreo-retinal surgeon at the Sir Charles Gairdner Hospital (SCGH). He has
recently been appointed as the Head of Department of Ophthalmology at SCGH. Dr. Raja undertook his primary medical degree
in India and completed his 3-year Masters in Ophthalmology from the world’s largest eye care system – the Aravind Eye Hospital
and Postgraduate Institute of Ophthalmology. He pursued further specialist registrar training in Ophthalmology in the United
Kingdom from 2004 -2012, completing fellowships in glaucoma and vitreo-retinal surgery at Liverpool and Oxford respectively.
Dr. Raja moved to Perth in 2013 to do his second fellowship in medical and surgical retina with Prof. Ian Constable at SCGH and
the Lion’s Eye Institute. In August 2014, Dr. Raja commenced private practice at the Joondalup Eye Clinic where he offers specialist
consultations and treatments for cataract, glaucoma and medical & surgical retinal conditions.
Prof Ian Constable
Professor Ian Constable AO was the Lions Foundation Professor of Ophthalmology at the University of Western Australia 1975-2008
and continues to work as a Professor at that University. His principal interests are surgery of the retina and cataract as well as diagnosis
and management of medical retinal conditions. He is Past President of the Asia Pacific Academy of Ophthalmology and the Asia Pacific
Vitreoretinal Society and is the founding Chairman of the Asia Pacific Association of Ophthalmology Professors. He has published over
400 peer-reviewed articles and was the Chairman of the WA State Science Council from 2000 to 2006. He continues a busy clinical
practice based at the Lions Eye Institute and Sir Charles Gairdner Hospital.
Dr Antonio Giubilato
Dr Antonio Giubilato underwent specialty fellowship training in glaucoma at the Royal Victorian Eye and Ear Hospital after training in
ophthalmology in Perth, Western Australia. This included both clinical and surgical management of glaucoma as well as research into
new therapies for the condition. He is presently consultant ophthalmologist in the Glaucoma Clinic at Royal Perth Hospital and also
consults at Bentley Hospital for public patients. Dr Giubilato is currently Director of Training for the WA branch of RANZCO and an
LSSF Board Member.
Talk Synopsis
Bridging eye health divides with technology
A/Prof Angus Turner
Retinal vein occlusion: pathogenesis, treatments and trials
Prof Ian McAllister
A review of the latest telehealth applications helping bring
optometrists and ophthalmologists together to care for regional
towns. The imaging and technology applications will be discussed
with a series of clinical case presentations to demonstrate telehealth
and outline eye health management of common presentations.
This lecture will cover new treatment techniques in the management
in retinal vein occlusion will cover the current approaches with their
advantages and disadvantages. It will also examine how techniques
can be modified in the future to produce more reliable and safer
visual results.
Diagnosis and management of Fuch’s dystrophy and
endothelial failure
A/Prof Steve Wiffen
“Doctor, what is wrong with my eye?”
A/Prof Mei-Ling Tay-Kearney
Causes of corneal endothelial failure will be discussed along with
management strategies and differential diagnosis. The pathogenisis
of Fuchs’ dystrophy will be discussed in detail.
Assessment and management of ptosis
Dr Jean-Louis deSousa
There are many causes of blepharoptosis, some associated with
serious and life threatening disease though most are a source of
mild visual and cosmetic symptoms. Treatment varies depending
on the cause and is not always surgical. An understanding of the
anatomy and physiology of the upper eyelid retractors forms the
basis of accurate assessment and management of blepharoptosis.
Diagnosis and management of Acanthameoba
Prof Geoffrey Crawford
Acanthamoeba can cause devastating visual complications and is
more commonly found in contact lens wearers in western countries.
This presentation will cover the differential diagnosis and possible
treatments.
Corneal dystrophies: diagnosis, differentials and management
Dr Andrea Ang
Corneal dystrophies are rare but understanding the management
options for patients is important.
Inflammatory eye disease grand rounds, diagnosis and management
Analysis of the optic nerve in glaucoma using OCT
Dr Vignesh Raja
This talk will focus on the diagnostic capability and pitfalls of
analysis of the optic nerve head in glaucoma using OCT technology,
mainly the Cirrus HD-OCT and the Heidelberg Spectralis. This talk
aims to highlight new parameters used in the evaluation of the
glaucomatous optic nerve head and its significance in day-to-day
practice.
Gene therapy development in the context of wet macular
degeneration
Prof Ian Constable
Wet AMD provides a crucial link between Optometry and
Ophthalmology as it demands prompt diagnosis , urgent
fluoresceine angiography and intravitreal injection. IV injections
have become a huge cost burden and long term imposition on
patients and their carers.Gene therapy developed in Perth may offer
good control with less injections.Results in the first safety cohort
of 6 patients are now published. The proceedure has proven to be
convenient and safe. Results in our 27 active gene therapy cohort
and randomized 13 controls will be independantly analysed in May/
June 2015.
Cataract and Glaucoma
Dr Antonio Giubilato
IOP - Myths, Truths, Interpretation and Management
Dr Antonio Giubilato
Angle closure glaucoma has a number of mechanisms- pupil
block, lens size,ciliary block and plateau iris . The lens/cataract has
an integral role in the pathogenesis of angle closure . The interrelationship between the role of the lens and other mechanisms
will be discussed and in particular the role of lens surgery in angle
closure will be put into context. In Open Angle Glaucoma especially
secondary causes e.g. Pseudo-exfoliation there remains a role for lens
surgery . Cataract surgery alone in glaucoma patients may result in a
small drop in IOP. After Trabeculectomy surgery significant rates of
cataract formation occur. Cataract surgery after glaucoma surgery can
result in glaucoma surgery failure . In open angle glaucoma cataract
surgery should not be
considered a treatment for glaucoma . However , The question “is my
patient better off having cataract surgery prior to glaucoma surgery ?”
should be asked.
Whilst IOP is no longer included in the definition of glaucomas
optic neuropathy it is integral in the management of glaucoma
as it remains the only modifiable risk factor. IOP measurement
is affected by numerous factors and the interpretation of “one
off IOP measurements “can be difficult . IOP can be measured
by different techniques with variable accuracy. The lowering of
IOP in glaucoma management should aim to slow the disease
by setting clinically appropriate target IOPs. A review of how to
measure IOP including the reliability of different instruments and
how IOP can vary with different ocular condition will be presented.
In addition the interpretation of “one off IOP readings “ in
glaucoma management will be discussed . The setting of clinically
achievable target pressures and how to interpret the adequacy of
management will evaluated
Program
Sunday 3 May 2015
McCusker Auditorium
Harry Perkins Institute
7.45
Registration
8:00
Bridging eye health divides with technology
A/Prof Angus Turner
9:20
Diagnosis and management of Fuch’s dystrophy and endothelial failure
A/Prof Steve Wiffen
10:00
Assessment and management of ptosis
Dr Jean-Louis deSousa
10:40
Diagnosis and management of Acanthameoba
Prof Geoffrey Crawford
11:20
Corneal dystrophies: diagnosis, differentials and management
Dr Andrea Ang
12:00
Lunch
12:30
Retinal vein occlusion: pathogenesis, treatments and trials
Prof Ian McAllister
13:50
“Doctor, what is wrong with my eye?”
A/Prof Mei-Ling Tay-Kearney
15:10
Analysis of the optic nerve in glaucoma using OCT
Dr Vignesh Raja
15:50
Gene therapy development in the context of wet macular degeneration
Prof Ian Constable
16:30
Cataract and Glaucoma
Dr Antonio Giubilato
17:10
IOP - Myths, Truths, Interpretation and Management
Dr Antonia Giubilato
Register
Th e Au st ralia n I nst it u t e of Opt omet r y
C o n f e r e n c e
2 0 1 1
Maximum CPD. Minimum Time.
Dates & Time
How to Pay
Sunday 3 May 2015 8:00 - 17:50
Registrations are open online now at
www.optomax.com.au
Cost
Enquiries
Earlybird*$349
Full
$449
*earlybird pricing available for first 50 registrants only
Maximum CPD points are achieved by successful completion of
the assessment
Web:
Email:
www.optomax.com.au
[email protected]
Terms & Conditions
Terms and conditions apply, please see the
website for details.
Venue & Access
McCusker Auditorium
Harry Perkins Institute
QQ Block, Sir Charles Gairdner Hospital
6 Verdun Street, Nedlands WA 6009
Cancellations
If received more than 14 days prior to the event
a full refund less $50 administration fee is
applicable. After that date no refund is available.
Parking
Sir Charles Gairdner Hospital is well served by public
transport. Parking is available onsite.
register online www.optomax.com.au